2025 United Kingdom Automated Cell Culture Equipment Market Revenue Opportunities Report
Description
The 2025 United Kingdom Automated Cell Culture Equipment Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automated Cell Culture Equipment Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automated Cell Culture Equipment Market in the United Kingdom are Merck KGaA, Lonza Group Ltd, Thermo Fisher Scientific Inc., and Corning Incorporated. These firms lead the market thanks to their broad portfolios that include automated cell culture instruments, consumables, and integrated bioprocessing platforms. Merck KGaA focuses on its BioContinuum™ platform that integrates cell culture and downstream processing to enable continuous biomanufacturing. Lonza is expanding scalable and closed system cell expansion solutions, while Thermo Fisher emphasizes strategic collaborations and innovative automated cell culture systems tailored for biotherapeutics. Corning contributes well-established consumable platforms to support automated workflows.
These companies benefit from the UK’s strong public-sector infrastructure, such as the Cell and Gene Therapy Catapult, promoting innovation in clinical and production automation. The UK market is projected to grow robustly with increasing demand for automated solutions meeting GMP guidelines, reducing contamination, and incorporating digital tools like AI for cell monitoring and process optimization. This fosters a competitive landscape where these four companies invest heavily in R&D and strategic partnerships to advance system functionality and scalability across research and industrial applications.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automated Cell Culture Equipment Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automated Cell Culture Equipment Market in the United Kingdom are Merck KGaA, Lonza Group Ltd, Thermo Fisher Scientific Inc., and Corning Incorporated. These firms lead the market thanks to their broad portfolios that include automated cell culture instruments, consumables, and integrated bioprocessing platforms. Merck KGaA focuses on its BioContinuum™ platform that integrates cell culture and downstream processing to enable continuous biomanufacturing. Lonza is expanding scalable and closed system cell expansion solutions, while Thermo Fisher emphasizes strategic collaborations and innovative automated cell culture systems tailored for biotherapeutics. Corning contributes well-established consumable platforms to support automated workflows.
These companies benefit from the UK’s strong public-sector infrastructure, such as the Cell and Gene Therapy Catapult, promoting innovation in clinical and production automation. The UK market is projected to grow robustly with increasing demand for automated solutions meeting GMP guidelines, reducing contamination, and incorporating digital tools like AI for cell monitoring and process optimization. This fosters a competitive landscape where these four companies invest heavily in R&D and strategic partnerships to advance system functionality and scalability across research and industrial applications.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
